republic-os/legislation/us/states/tn/113/sb-2297.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68.	Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68.	us/states/tn	Tennessee General Assembly	113	SB 2297	Tennessee SB 2297 (113)	bill	Drugs Prescription	enacted	Haile	3	23	3	2024-01-30	2024-05-13	openstates	ocd-bill/c9752839-bd22-492a-bb33-f5b1b128d402	http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB2297&GA=113	4b14aa3117ae2f0fd1e70f31bdeb7e4f1604be1b7da9316a1fde2ebe7aca4f87	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-tn

Tennessee SB 2297 (113) — Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Amendment HA0776 (committee substitute) — source
2. Amendment SA0800 (committee substitute) — source
3. Current Version (committee substitute) — source

Votes

• SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 6, Nays 3 PNV 0 3/19/2024 Passed — 6–3 (pass) · upper
• FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/15/2024 Passed (1) — 88–5 (pass) · lower
• FLOOR VOTE: as Amended Third Consideration 3/28/2024 Passed (1) — 27–3 (pass) · upper

Sponsors

• Haile — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2024-01-30 Filed for introduction filing
• 2024-01-31 Introduced, Passed on First Consideration introduction
• 2024-02-01 Passed on Second Consideration, refer to Senate Health and Welfare Committee passage
• 2024-03-13 Placed on Senate Health and Welfare Committee calendar for 3/19/2024
• 2024-03-13 Sponsor change. sponsorship
• 2024-03-19 Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 6, Nays 3 PNV 0
• 2024-03-20 Sponsor(s) Added. sponsorship
• 2024-03-26 Placed on Senate Regular Calendar for 3/28/2024
• 2024-03-28 Sponsor(s) Added. sponsorship
• 2024-03-28 Engrossed; ready for transmission to House receipt
• 2024-03-28 Passed Senate as amended, Ayes 27, Nays 3 passage
• 2024-03-28 Senate adopted Amendment (Amendment 1 - SA0800)
• 2024-04-01 Rcvd. from S., held on H. desk.
• 2024-04-15 Passed H., Ayes 88, Nays 5, PNV 0 passage
• 2024-04-15 Am. withdrawn. (Amendment 1 - HA0776) amendment-withdrawal
• 2024-04-15 Subst. for comp. HB. substitution
• 2024-04-16 Signed by Senate Speaker passage
• 2024-04-16 Enrolled and ready for signatures enrolled
• 2024-04-18 Signed by H. Speaker passage
• 2024-04-19 Transmitted to Governor for action. executive-receipt
• 2024-05-01 Signed by Governor. executive-signature
• 2024-05-13 Effective date(s) 05/01/2024
• 2024-05-13 Pub. Ch. 857

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/c9752839-bd22-492a-bb33-f5b1b128d402. Confidence: reported (aggregated from official Tennessee legislature records).